C
NexgenRx Inc. NXG.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 189.70K -17.20K -46.90K -244.70K -229.30K
Total Depreciation and Amortization 933.30K 946.30K 961.30K 969.10K 983.50K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 47.50K 51.90K 51.20K 53.20K 155.70K
Change in Net Operating Assets -451.30K 169.60K -76.20K 172.60K -608.10K
Cash from Operations 719.40K 1.15M 889.50K 950.30K 301.80K
Capital Expenditure -50.50K -84.60K -66.30K -57.30K 195.10K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -168.50K -124.80K -158.70K -127.50K -137.90K
Cash from Investing -219.00K -209.40K -225.00K -184.80K 57.30K
Total Debt Issued -- -- -- -- --
Total Debt Repaid -98.60K -89.40K -82.60K -79.20K -78.80K
Issuance of Common Stock 187.50K 187.50K 187.50K 62.50K 62.50K
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -639.70K -640.10K -667.70K -667.60K -384.20K
Other Financing Activities 0.00 33.00K -- -- --
Cash from Financing -573.70K -542.60K -589.60K -679.70K -396.00K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -73.50K 398.50K 74.60K 85.50K -37.20K
Weiss Ratings